The Cost of Brand Drug Product Hopping (8-page PDF) 

Source:  Medical Marketing in the United States, 1997-2016 (JAMA)

Source: MEDICARE PART D: Use of Pharmacy Benefit Managers and Efforts to Manage Drug Expenditures and Utilization (78-pg GAO PDF) ...

Source: ASHP national survey of pharmacy practice in hospital settings: Workforce—2018

Source: Academia and industry: allocating credit for discovery and development of new therapies

Source: How Does Prescription Drug Spending and Use Compare Across Large Employer Plans, Medicare Part D, and Medicaid?

Source: U.S. Distribution and Reimbursement System: Patient- Administered Outpatient Drugs

Source: The FDA’s Drug Pricing Strategy: What’s New? "...To help track the FDA’s progress in implementing its strategy, we...

Source: The Global Use of Medicine in 2019 and Outlook to 2023: Forecasts and Areas to Watch (reg.reqd.)

Source: Orphan Drugs in the United States: Exclusivity, Pricing and Treated Populations (23-pg PDF, registration reqd.)

    Source: WHO Report on Surveillance of Antibiotic Consumption   (115-pg PDF) "Antimicrobial resistance is a major threat ...

Source: Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion "... Teva Pharmaceutical Industries Ltd. plummeted the most i...

  Source: Drug Price Forecast Highlights: July-August 2018

      Source: The FDA is approving more generic drugs than ever before, faster than ever before. Is it enough to lower drug costs?...

Source: Why Retail Pharmacies Still Overcharge Uninsured Patients—And What That Means for Amazon

Source: Reforming Biopharmaceutical Pricing at Home and Abroad (28-page CEA PDF)

Source: Drug Industry: Profits, Research and Development Spending, and Merger and Acquisition Deals (73-pg GAO PDF)

Source: Health care profits concentrated at drug companies "Ninety-nine of the largest publicly traded health care companies cu...

Source: A $1.6B cut to 340B payments, plus outpatient TKA: Our key takeaways on the 2018 Outpatient Final Rule